review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.3810/PGM.2010.07.2171 |
P8608 | Fatcat ID | release_snmoetqqmrgylg4x5cp3xo4yea |
P698 | PubMed publication ID | 20675967 |
P2093 | author name string | Marco Mula | |
P2860 | cites work | Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) | Q21999020 |
Falret's discovery: the origin of the concept of bipolar affective illness. Translated by M. J. Sedler and Eric C. Dessain | Q22241889 | ||
The postictal state: a neglected entity in the management of epilepsy | Q28212574 | ||
Organic mania induced by phenytoin: a case report | Q28341525 | ||
A systematic review of the mortality of depression | Q33534388 | ||
The relationship of neuropsychological functioning to quality of life in epilepsy. | Q51121368 | ||
Prodromal symptoms in epileptic patients: clinical characterization of the pre-ictal phase. | Q51875058 | ||
Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. | Q51895857 | ||
Patient-validated content of epilepsy-specific quality-of-life measurement. | Q52892849 | ||
Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. | Q53357506 | ||
A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. | Q53512831 | ||
Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. | Q53615836 | ||
Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy | Q57544878 | ||
The evolving bipolar spectrum. Prototypes I, II, III, and IV. | Q33768203 | ||
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity | Q33844558 | ||
Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders | Q33925909 | ||
The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 | ||
Validity of the mood disorder questionnaire: a general population study | Q34167575 | ||
A permanent change in brain function resulting from daily electrical stimulation | Q34225550 | ||
The natural history of epilepsy: an epidemiological view. | Q34349568 | ||
Negative effects of antiepileptic drugs on mood in patients with epilepsy | Q34580773 | ||
Psychotropic effects of antiepileptic drugs | Q34589572 | ||
The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence | Q34628339 | ||
Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials | Q34893595 | ||
Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment | Q35074484 | ||
Peri-Ictal Behavioral and Cognitive Changes. | Q35074501 | ||
Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 | ||
The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. | Q35975365 | ||
The structure of lifetime manic-hypomanic spectrum | Q36070621 | ||
Antiepileptic drug-induced mania in patients with epilepsy: what do we know? | Q36556140 | ||
Antiepileptic drugs and mood stability. | Q36827444 | ||
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions | Q36888606 | ||
Epilepsy and mood disorders | Q37019190 | ||
Depression in epilepsy: a complex relation with unexpected consequences | Q37101119 | ||
Psychopharmacology of topiramate: from epilepsy to bipolar disorder | Q37166152 | ||
Predictors of pharmacoresistant epilepsy | Q40194333 | ||
Neurochemical underpinnings in bipolar disorder and epilepsy | Q40416216 | ||
Signal transduction pathways. Molecular targets for lithium's actions | Q40437069 | ||
A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures | Q41189037 | ||
Mania precipitated by carbamazepine withdrawal | Q42557492 | ||
Topiramate induced manic episode | Q42563500 | ||
First break of mania associated with topiramate treatment | Q43689762 | ||
Extending indications for long-term pharmacotherapy: opportunities and challenges | Q43843034 | ||
Manic episode in epilepsy and bipolar I disorder: a comparative analysis of 13 patients | Q43905226 | ||
On the prevalence of bipolar disorder in epilepsy | Q44703851 | ||
Zonisamide-induced depression and mania in patients with epilepsy | Q44717938 | ||
Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 | ||
Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study | Q46574204 | ||
Mania following temporal lobectomy | Q47611908 | ||
Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period | Q48320278 | ||
Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy | Q48473722 | ||
Oxcarbazepine improves mood in patients with epilepsy. | Q50909818 | ||
Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. | Q51006632 | ||
Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. | Q51032804 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 17-23 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Postgraduate Medicine | Q7234297 |
P1476 | title | The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal | |
P478 | volume | 122 |
Q30463349 | New insights into behaviour using mouse ENU mutagenesis |
Q37880900 | Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications |
Q34350056 | Suicide risk in people with epilepsy taking antiepileptic drugs |
Q38780173 | The interictal dysphoric disorder of epilepsy: Legend or reality? |
Search more.